The relationship between gastroesophageal reflux, intestinal metaplasia and adenocarcinoma of the esophagus

Langenbeck's Archives of Surgery

Volumn 385, Issue 5, 2000, Pages 309-316

  Stein, H J ^a   Feith, Marcus ^a   Feussner, H ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Anti reflux surgery; Barrett cancer; Barrett esophagus; Esophageal cancer; Gastroesophageal reflux; Intestinal metaplasia; Medical therapy; Mucosal ablation

Indexed keywords

ADENOCARCINOMA; ARTICLE; BARRETT ESOPHAGUS; DISEASE ASSOCIATION; ESOPHAGUS CARCINOMA; GASTROESOPHAGEAL REFLUX; HISTOPATHOLOGY; HUMAN; INTESTINE METAPLASIA; PRIORITY JOURNAL; SURGICAL APPROACH;

EID: 0033863939     PISSN: 14352443     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004230000160     Document Type: Article

References (44)

1. El-Serag HB, Sonnenberg A (1998) Opposing time trends of peptic ulcer and reflux disease. Gut 48: 327-333
2. Devesa SS, Blot WJ, Fraumeni JF Jr (1998) Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 83: 2049-2053
3. Stein HJ, Siewert JR (1993) Barren's esophagus: pathogenesis, epidemiology, functional abnormalities, malignant degeneration and surgical management. Dysphagia 8: 276-288
4. Spechler SJ, Goyal RK (1996) The columnar-lined esophagus, intestinal metaplasia, and Norman Barrett. Gastroenterology 110: 614-621
5. DeMeester SR, DeMeester TR (2000) Columnar mucosa and intestinal metaplasia of the esophagus: fifty years of controversy. Ann Surg 231: 303-321
6. Lagergren JL, Bergstrom R, Lindgren A. Nyren O (1999) Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. New Engl JMed340: 825-831
7. Barrett M (1957) The lower esophagus lined by columnar epithelium. Surgery 41:881-894
8. Stein HJ, Siewert JR (1994) Barren's Ösophagus - Endobrachyösophagus: Norman Rupert Barrett und Jean-Louis Lortat-Jakob. Chirurg 88: 110-111
9. Sampliner RE (1998) Practice guidelines on the diagnosis, surveillance, and therapy of Barren's esophagus. The Practice Parameters Committee of the American College of Gastroenterology. Am J Gastroenterol 93: 1028-1032
10. Spechler SJ (1999) The role of gastric carditis in metaplasia and neoplasia at the gastroesophageal junction. Gastroenterology 117: 218-228
11. Stein HJ, Feith M (1999) Pathogenesis of Barren's esophagus: role of gastroesophageal reflux and helicobacter pylori. In: Peracchia A, Bonavina L (eds) Barren's esophagus: an up-to-date. Edra, Milan, pp 17-24
12. Hirota WK, Loughney TM, Lazas DJ, Maydonovitch CL, Rholl V, Wong RKH (1999) Specialized intestinal metaplasia, dysplasia, and cancer of the esophagus and esophagogastric junction: prevalence and clinical data. Gastroenterology 116: 277-285.
13. Nandurka S, Talley NJ (1999) Barren's oesophagus: the long and the short of it. Am J Gastroenterol 94: 30-40.
14. Fera M (2000) Latest trends in incidence and prevalence of specialized intestinal metaplasia, Barren's esophagus and adenocarcinoma of the gastroesophageal junction. World J Surg (in press)
15. El-Serag HB, Sonneberg A, Jamal MM, Kunkel D, Crooks L, Fedderson RM (1999) Characteristics of intestinal metaplasia in the gastric cardia. Am J Gastroenterol 94: 622-627
16. Hackelsberger A, Günther T, Schultze V, Manes G, Dominguez-Munoz JE, Roessner A, Malfertheimer P (1998) Intestinal metaplasia at the gastrooesophageal junction: Helicobacter pvlori gastritis or gastroesophageal reflux disease? Gut 43: 17-21
17. Pereira AD, Suspiro A, Chaves P, Saraiva A, Gloria L, de Almeida JC, Leitao CN, Soares J, Mira FC (1998) Short segments of Barren's epithelium and intestinal metaplasia in normal appearing oesophagogastric junctions: the same or two different entities? Gut 42: 659-662
18. Stein HJ, Hoeft S, DeMeester TR (1993) Functional foregut abnormalities in Barren's esophagus. J Thorac Cardiovasc Surg 105: 107-111
19. Stein HJ, Kauer WKH, Feussner H, Siewert JR ( 1998) Bile reflux in benign and malignant Barren's esophagus. Effect of medical acid suppression and fundoplication. J Gastrointest Surg 2: 333-341
20. Oberg S, DeMeester TR, Peters JH, Hagen JA, Nigro JJ, DeMeester SR, Theisen J, Campos GM, Crookes PF ( 1999) The extent of Barren's esophagus depends on the status of the lower esophageal sphincter and the degree of esophageal acid exposure. J Thorac Cardiovasc Surg 117: 572-580
21. Fitzgerald RC, Omary MB, Triadiafilopoulos G (1996) Dynamic effects of acid on Barren's esophagus. J Clin Invest 98: 2120-2128
22. Marshall REK, Anggiansah A, Owen JW (1997) Bile in the esophagus. Clinical relevance and ambulatory detection. BrJ Surg 84: 21-28
23. Miwa K, Hattori T, Miyazaki I (1995) Duodenogastric reflux and foregut carcinogenesis. Cancer 75: 1426-1432
24. Stein HJ, Kauer WKH, Feussner H, Siewert JR (1999) Bile acids as components of the duodenogastric refluate: detection, relationship to bilirubin, mechanism of injury and clinical relevance. Hepatogastroenterology 46: 66-73
25. Theisen J, Peters J, Stein HJ (2000) Experimental evidence for mutagenic potential of duodenogastric juice on Barren's mucosa. World J Surg (in press)
26. Rösch W, Jaspersen D (1998) Konservative Behandlung der gastroösophagealen Refluxkrankheit. Deutsches Ärzteblatt 95: 2468-2472
27. Stein HJ, Feith M, Siewert JR (2000) Malignant degeneration of Barren's esophagus. Clinical point of view. Recent Results Cancer Res 155: 119122
28. Welscher GJ, Profanier C, Gadenstatter M, Perdikis G, Glaser K, Hinder RA (1997) Medical treatment of gastroesophageal reflux disease does not prevent the development of Barren's metaplasia and poor esophageal body motility. Langenbecks Arch Chir 382: 95-99
29. Klinkenberg-Knol EC, Nelis F, Dent J, Snel P, Mitchell B, Prichard P, Lloyd D, Havu N, Frame MH, Roman J, Walan A, Group LT (2000) Long-term omeprazole treatment in resistant gastroesophageal reflux disease: efficacy, safety, and influence on gastric mucosa. Gastroenterology 118: 661-669
30. Kuipers EJ, Meuwissen SGM (2000) The efficacy and safety of long-term omeprazole treatment for gastroesophageal reflux disease. Gastroenterology 118: 795-798
31. Peghini PL, Katz PO. B racy NA, Castell DO (1998) Nocturnal recovery of gastric acid secretion with twicedaily dosing of proton pump inhibitors Am J Gastroenterol 93: 763-767
32. Katzka DA, Castell DO (1994) Successful elimination of reflux symptoms does not insure adequate control of acid reflux in patients with Barren's esophagus. Am J Gastroenterol 89: 989-991
33. Ouatu-Lascar R, Triadafilopoulos G (1998) Complete elimination of reflux symptoms does not guarantee normalization of intraesophageal acid reflux in patients with Barrett's esophagus. Am J Gastroenterol 93: 711-716
34. Mulligan ED, Purcell T, Lawlor P, Reynolds JV, Byrne PJ (2000) Symptoms are a poor indication of severity of reflux in Barrett's oesophagus. BrJSurg 87: 362-373
35. Bremner CG, Demeester TR (1998) Proceedings from an international conference on ablation therapy for Barrett's mucosa. Dis Esophagus 11: 1-27
36. Van Laethem JL, Cremer M, Peny MO. Delhaye M. Deviere J (1998) Eradication of Barren's mucosa with argon plasma coagulation and acid suppression: immediate and mid term results. Gut 43: 747-751
37. Overholt BF, Panjehpour M, Haydek JM (1999) Photodynamic therapy for Barren's esophagus: follow-up in 100 patients. Gastrointest Endosc 49: 1-7
38. Sharma P. Morales TG, Bhattacharyya A, Garewal HS, Sampliner RE (1998) Squamous islands in Barren's esophagus: what lies underneath? Am J Gastroenterol 93: 332-335
39. Chow WH, Blaser MJ, Blot WJ, Gammon MD, Vaughan TL, Risch HA, Perez-Perez GI. Schoenberg JB, Stanford JL, Rotterdam H, West AB, Fraumeni JF Jr (1998) An inverse relation between cagA.+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenoearcinoma. Cancer Res 58: 588-590
40. Stein HJ, Feussner H, Siewert JR (1998) Indikationen zur Antirefluxchirurgie des Ösophagus. Chirurg 69: 132-40
41. van Sandick JW. van Lanschot JJ. Kuiken BW, Tytgat GN, Offerhaus GJ, Obertop H (1998) Impact of endoscopie biopsy surveillance of Barren's oesophagus on pathological stage and clinical outcome of Barren's carcinoma. Gut 43: 216-222
42. Reid BJ, Weinstein WM, Lewin KJ, Haggitt RC, Van Deventer G. Den Besten L, Rubin CE (1988) Endoscopie biopsy can detect high grade dysplasia or early adenocarcinoma in Barren's oesophagus without grossly recognisable neoplastic lesion. Gastroenterology 94: 81-90
43. Provenzale D, Kemp JA, Arora S, Wong JB (1994) A guide for surveillance of patients with Barren's esophagus. Am J Gastroenterol 89: 670-680
44. Stein HJ, Feith M, Müller J, Werner M, Siewert JR (2000) Limited resection for early Barren's cancer. Ann Surg (in press)